| Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other healthcare-related products. During the year ended December 31, 2007, the Company had three segments: Pharmaceuticals, Nutritionals and ConvaTec. The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business. The other two segments ' Nutritionals and ConvaTec ' comprised the Company's Health Care Group. The Nutritionals segment consists of Mead Johnson Nutritionals (Mead Johnson), primarily an infant formula and children's nutritionals business. The ConvaTec segment consisted of the ostomy, wound and skin care business. On January 7, 2008, the Company completed the sale of its Medical Imaging business to Avista Capital Partners L.P. In August 2008, BMS announced that Nordic Capital Fund VII and Avista Capital Partners completed their acquisition of ConvaTec. |
